Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Heliospectra AB (publ) announces the results of the rights issue

The subscription period for the rights issue in Heliospectra AB (publ) was completed on November 19, 2020 and the outcome of the rights issue shows that the rights issue was subscribed by approximately 124 percent. The rights issue, which was covered by subscription and guarantee commitments corresponding to 100 percent, was subscribed by approximately 91,6 percent with the support of unit rights and approximately 32,6 percent without the support of unit rights. The issue guarantee has therefore not been used. The rights issue provides the Company with approximately SEK 50,6 million, before

Qlife receives order for COVID-19 tests to European Women’s Handball Championship 2020

Qlife announces today that the company is entering into an agreement to deliver COVID-19 tests for the European Women’s Handball Championship 2020. The event will take place in Herning and Kolding, Denmark December 3-20. The testings will be performed daily, and the company expects approximately 5-6,000 tests during the tournament.”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high precision – as we know it from the healthcare system – and with answers

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 101 - 24 NOVEMBER 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcement no. 90. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451

Smoltek extends license agreement for evaluation of the company’s CNF-MIM-technology

Smoltek Nanotech Holding AB (“Smoltek”) announces that the company has come to an agreement to extend the license agreement signed with a global manufacturer of electronic components for evaluation of Smoltek’s CNF-MIM technology. In addition to further evaluation, the parties will also discuss the way forward after the evaluation, including a potential broadening of the collaboration. This press release is an English version of the previously published Swedish version, which has interpretative preference.This spring, Smoltek announced two separate license agreements for technical and

Recipharm announces signature of letter of intent for aseptic fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate (mRNA-1273)

Recipharm, a leading contract development and manufacturing organisation (CDMO) announces that it has signed a letter of intent with Moderna, a U.S. based biotech company, to formulate, fill and finish mRNA-1273, Moderna’s COVID-19 vaccine candidate. The activity will be performed in Recipharm’s drug product manufacturing facility located in Monts, France. Recipharm has reserved capacity to support the anticipated demand for the vaccine and is already in the process of recruiting additional staff and making certain investments to enable technology transfer and scale-up to commence

EG7 Broadcasts Presentation and Live Q&A

EG7 wants to inform its shareholders and other interested parties that a new video presentation will be uploaded on the company’s website at 9:00am CET on November 25, 2020. The purpose of the broadcast is to provide all shareholders with a presentation of the Q3 2020 interim report. EG7 will also broadcast a live Q&A where shareholders and other interested parties will be provided an opportunity to ask questions to the company at 9:30am CET on November 25, 2020. To access the video presentation, please use the following link at the given time: https://www.enadglobal7.com/financial-

Interim report January – September 2020

Press release: Uppsala, November 24, 2020. Pharmacolog i Uppsala AB’s (publ) interim report for the period January – September is now available on the company’s webbsite http://www.pharmacolog.com (Swedish only)Tredje kvartalet 1 juli 2020 – 30 september 2020 · Bolagets nettoomsättning för perioden uppgick till 16 (28) KSEK. · Rörelseresultatet för perioden uppgick till -2 042 (-3 155) KSEK. · Nettoresultat per aktie före och efter utspädning var för perioden -0,36 (-0,32) SEK. Perioden 1 januari 2020 – 30 september 2020 · Bolagets nettoomsättning för perioden uppgick

Spanish shipbuilder Gondan Shipyard orders PEMA VRWP-C robot welding solution

Gondan Shipyard is located in the Principality of Asturias. The shipyard has over 90-year-long experience in vessel manufacturing. Photo by Gondan Shipyard.   The Asturian ship manufacturer Gondan Shipyard has placed an order for a compact robot welding solution, PEMA VRWP-C. The shipyard, located in the North of Spain, has a long history in the industry as it has over 90-year-long experience in vessel manufacturing. Gondan is known for its accomplishments in shipbuilding, such as pioneering in manufacturing environmentally friendly vessels, but also vessels for very deep

Adverty is granted US patent for in-game ad viewability technology BrainImpression™

Adverty AB (publ) has been granted a patent by the United States Patent and Trademark Office for its in-game ad viewability technology BrainImpression™; a groundbreaking method for determining ad viewability and impressions within complex gaming environments. The patented invention is one of the core functionalities of Adverty’s leading in-game advertising platform.Adverty, the leading in-game platform for advertisers, agencies and game developers, today announces the notice of allowance for its in-game ad viewability technology patent by the United States Patent and Trademark Office. The

BillerudKorsnäs solution for E-Commerce mailers - the conscientious alternative for consumers and online retailers

E-Commerce mailer bags made from BillerudKorsnäs’ Xpression E-com paper have 50 percent lower fossil emissions than virgin plastic mailer bags and using this leads to the removal of biogenic carbon from the atmosphere. This is proven by a new independent study that compares the environmental impact of different types of e-commerce packaging. The global E-commerce market was already growing faster than other traditional channels prior to Covid-19, but the pandemic has boosted the move from brick and mortar stores to online purchasing. This transition is driving demand for packaging

Corruption remains a major problem in Asia, damaging trust in government, survey finds

Nearly one in five respondents paid a bribe while accessing essential services such as health careA report released today by Transparency International reveals that citizens across 17 countries in Asia report stagnant or rising levels of corruption, undermining equitable access to public services and trust in government.  Read the report  The report, Global Corruption Barometer – Asia, finds that three-quarters of respondents believe that government corruption is a big problem in their country, with nearly one in five people (19 per cent) paying

Everfuel – Company presentation

Herning, Denmark, 24 November 2020 – Everfuel A/S is presenting at the Fearnley Securities’ Annual Renewables Seminar today. Please see the attached presentation.   For additional information, please contact Jacob Krogsgaard, CEO, +45 2871 8945   About Everfuel | www.everfuel.comEverfuel is making green hydrogen for zero emission mobility commercially available across Europe, offering competitive all-inclusive hydrogen supply- and fueling solutions. We own and operate green hydrogen infrastructure and partner with vehicle OEMs to connect the entire hydrogen value chain

InDex Pharmaceuticals presents at Redeye Life Science Day 2020

November 24, 2020 – InDex Pharmaceuticals Holding AB (publ) today announced that CEO Peter Zerhouni will present the company at Redeye Life Science Day at 13:50 CET on November 26. The presentation will be livestreamed and can be followed at https://www.redeye.se/events/792760/redeye-life-science-day, where the presentation also will be available afterwards.The presentation will also be available afterwards on the company’s page in Redeye Universe (www.redeye.se/company/index-pharmaceuticals) and on the company’s website (www.indexpharma.com).   For more information: Peter Zerhouni,

Storytel names Camilla Silfvenius Global Head of Content Acquisition

Camilla Silfvenius will take on the newly created position of Global Head of Content Acquisition at Storytel on 1 March 2021. In her new role, she will play a key part in the company’s high-quality content development and the continued expansion of Storytel’s leading global catalogue. Camilla was most recently the Head of Content at Nextory. At Storytel, she will report to Helena Gustafsson, Chief Content Strategy Officer.“Camilla is a star in the creative and dynamic content market for audio that is developing at high speed. Her broad experience from the publishing industry, her feel for

Operations update

EnQuest PLC, 24 November 2020 Operations update Strong Kraken performance continues · Group production averaged 60,777 Boepd in the ten months to end October 2020; full year production expected to be slightly below the mid-point of the 57,000 to 63,000 Boepd guidance range · As previously guided, Group production is lower in the second half compared to the first half of the year,  reflecting the maintenance shutdown schedule as well as an unplanned outage at PM8/Seligi. The PM8/Seligi outage has no material impact on cash flow due to the Production Sharing Contract cost

The exercise period for Initiator Pharma’s warrants of series TO 2 begins today

Today, the 24[th] of November 2020, the exercise period for Initiator Pharma A/S (“Initiator” or the “Company”) warrants of series TO 2 that were issued in connection with the Company’s latest rights issue of units and directed issue of units commences. The exercise period runs until the 15[th] of December 2020. Upon full exercise of warrants, Initiator Pharma will receive approximately SEK 16.4 million before issue costs – capital that will finance the completion of the Company’s clinical phase IIa study. Sedermera Fondkommission is the financial adviser and Markets & Corporate Law Nordic AB

OXE Marine AB (publ) Interim report 1 July to 30 September 2020

OXE Marine AB (publ) (NASDAQ STO: OXE, OTCQX: CMMCF)  INTERIM REPORT Third quarter 2020 · Net turnover of SEK 3.4m (SEK 23.3m) · Gross Profit of SEK 0.8m (SEK 2.8m) or gross margin of 24% (12%) · Operating Loss/EBIT of SEK -25.1m (SEK -18.7m) · Net loss for the period of SEK -27.3m (SEK -20.8m) · Order book grew by 77% to EUR 9.6m or SEK 101m (EUR 5.4m or SEK 57m as at end of Q2 2020) January - September 2020 · Year to date net turnover of SEK 35.4m (SEK 50.9m) · Gross Profit of SEK 4.9m (SEK -7.6m) or gross margin of 14% (-15%) · Operating Loss/EBIT of

Investment Outlook: Recovery, temporarily interrupted

On the one hand, there are worries related to the second wave of the COVID-19 pandemic and the economic impact of lockdowns. On the other hand, there are encouraging indications about impending vaccines and a US election outcome that was well received by investors. Central banks and governments are also working hard to create better conditions, while prices of financial assets are fairly high in a historical perspective.“There may be more instability in the short term, since the powerful stock market recovery has led to greater sensitivity to setbacks. But if we lift our gaze a bit, the

Husqvarna Group is further expanding its offering in surface preparation through the acquisition of Blastrac

Husqvarna Group’s Construction Division has signed an agreement to acquire Blastrac,a leading provider of surface preparation technologies for the global construction and remediation industry.“The acquisition of Blastrac strengthens and complements our organic growth ambitions, as we are further expanding into complementary surface preparation solutions. This will enable us to provide customers with a complete range of solutions for any given surface preparation task,” said Henric Andersson, President & CEO, Husqvarna Group. The Blastrac product portfolio includes high-quality and

Balder completes a directed issue of 6.5 million Class B shares, raising proceeds of approximately SEK 2,945 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE SECTION “IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE.Fastighets AB Balder (publ) (“Balder”) (Nasdaq Stockholm: BALD B) has, based on the authorization granted by Balder’s Annual General Meeting on 11 May 2020, resolved to carry out a direct

Webstep ASA: Application of shares by primary insiders

Oslo, 24 November 2020. Reference is made to the stock exchange announcement by Webstep ASA ("Webstep") on 23 November 2020 regarding the offer of shares to employees (the "Offer").The application period in the Offer commenced on 23 November 2020. As of today, 24 November 2020, the following primary insiders have applied for shares in the Offer:  · Arne Lee Norheim (CEO), for an amount of NOK 25,000 (excluding the discount given in the Offer); · Liv Annike Kverneland (CFO), for an amount of NOK 25,000 (excluding the discount given in the Offer); · Arnt Roger Aasen (Board Member,

Archer secures long term platform drilling and maintenance contract from Aker BP for offshore Norway

Hamilton, Bermuda (November 24, 2020) Archer has secured a five-year contract from Aker BP with an additional three-year extension option for the provision of platform drilling operations and maintenance services on the Ula and Valhall installations in the Norwegian sector of the North Sea. The contract will commence January 1, 2021 in direct continuation of the current contract. Archer will deliver platform drilling, maintenance services and intervention support, including further integrated engineering, rental equipment and well services where required as part of its #OneArcher

Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma

· An 18-month analysis shows that median Overall Survival (mOS) will be at least 18.2 months for first-line patients receiving ONCOS-102 plus chemotherapy, compared to mOS of 14.2 months or less in the chemotherapy-only control group · ONCOS-102-treated patients show broad and powerful immune activation, associated with better survival outcome Oslo, Norway, 24 November 2020 - Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today releases 18-month follow-up data from the randomized phase I/II trial of

Webstep ASA: Long-Term Incentive Program – grant of share options

Oslo, 24 November 2020: With reference to the announcement of 10 November 2020, Webstep ASA has today granted share options to 14 executives and managers of the Company and its subsidiaries. The long-term incentive program was authorized by the Company’s Annual General Meeting on 7 May 2020.The strike price of the share is 22.73 equal to the volume weighted average market price for trades in the share on the Oslo Stock Exchange six business days prior to the grant date. 546,000 share options are allocated and following the grant the total outstanding share options in the Company is 1,014,

There are no items matching the current filter
There are no more items matching the current filter
Back to top